China SXT Pharmaceuticals, Inc. (SXTC)
SXTC Stock Price Chart
Explore China SXT Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze SXTC price movements and trends.
SXTC Company Profile
Discover essential business fundamentals and corporate details for China SXT Pharmaceuticals, Inc. (SXTC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
4 Jan 2019
Employees
75.00
Website
https://www.sxtchina.comCEO
Feng Zhou
Description
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.
SXTC Financial Timeline
Browse a chronological timeline of China SXT Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 30 Oct 2023
Stock split effective on 5 Oct 2023
Shares were split 1 : 25 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 17 Jul 2023
Stock split effective on 19 May 2022
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Mar 2022
EPS came in at $2.23 , while revenue for the quarter reached -$11.50M .
Earnings released on 31 Mar 2021
EPS came in at $0.37 , while revenue for the quarter reached -$9.33M .
Stock split effective on 22 Feb 2021
Shares were split 1 : 4 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Sept 2020
EPS came in at $0.03 , while revenue for the quarter reached $1.93M .
SXTC Stock Performance
Access detailed SXTC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.